Wastl Human Performance Laboratory, Purdue University
West Lafayette, Indiana, 47907, United States
NCT Number: NCT01199926
The study was designed to assess the effects of vitamin D supplementation during exercise training on body composition, muscle function, and glucose tolerance. The investigators hypothesis for these studies is that vitamin D supplementation enhances exercise-induced increases in strength and lean mass, potentially through enhancing insulin sensitivity and reducing inflammation.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Phase 4
West Lafayette, Indiana, 47907, United States
The study was designed to assess the effects of vitamin D supplementation during exercise training on body composition, muscle function, and glucose tolerance. It was a double-blind, randomized, placebo-controlled, clinical trial with participants randomized into either a 4,000 IU/day vitamin D or placebo group and all participants completed 12 wks (3 d/wk) of exercise training.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4000 IU of vitamin D per day for 12 weeks.
Other names: cholecalciferol
Placebo (microcrystalline cellulose) ingestion each day for 12 weeks.
Other names: microcrystalline cellulose
Time frame: three months
The primary endpoint is the change in lean mass (kilograms) after the three month resistance exercise intervention.
Time frame: three months
The primary endpoint is the change in the area under the glucose curve following an oral glucose tolerance test prior to and after the three month intervention.
Time frame: three months
The primary endpoint is the change in C reactive protein after the three month intervention
Purdue University
Other
Impact of Vitamin D Supplementation on Strength and Lean Mass Accumulation During an Exercise Intervention
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07241741
Body Weight, C-reactive Protein
View Trial DetailsNCT05295719
Body Weight, Dyslipidemias
Lubbock, Texas, United States
View Trial DetailsNCT05017571
Body Weight, Diabetes Mellitus
Bethesda, Maryland, United States
View Trial DetailsNCT06242535
Behavior, Behavioral Symptoms
Gillette, Wyoming, United States
View Trial Details